Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Albumin-Bound Paclitaxel × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Recurrence 1 Oropharyngeal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mouth Neoplasms 1 Metastatic Adenocarcinoma of the Pancreas 1 Lip Neoplasms 1 Laryngeal Neoplasms 1 Gastric Adenocarcinoma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡